U.S. Markets closed

National Health Investors, Inc. (NHI)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
65.69-0.56 (-0.85%)
At close: 4:00PM EDT

65.69 0.00 (0.00%)
After hours: 4:15PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close66.25
Bid65.66 x 2900
Ask67.79 x 800
Day's Range65.28 - 69.81
52 Week Range31.37 - 91.12
Avg. Volume344,537
Market Cap2.933B
Beta (5Y Monthly)0.85
PE Ratio (TTM)15.59
EPS (TTM)4.21
Earnings DateNov 05, 2020 - Nov 09, 2020
Forward Dividend & Yield4.41 (6.66%)
Ex-Dividend DateJun 29, 2020
1y Target Est59.50
  • National Health Investors (NHI) Surpasses Q2 FFO and Revenue Estimates

    National Health Investors (NHI) Surpasses Q2 FFO and Revenue Estimates

    National Health Investors (NHI) delivered FFO and revenue surprises of 2.10% and 1.43%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?


    NHI Announces Second Quarter 2020 Results

    MURFREESBORO, TN / ACCESSWIRE / August 10, 2020 / National Health Investors, Inc.

  • Benzinga

    Earnings Outlook For National Health Investors

    On Monday, August 10, National Health Investors (NYSE: NHI) will release its latest earnings report. Benzinga's outlook for National Health Investors is included in the following report.Earnings and Revenue Based on National Health Investors management projections, analysts predict EPS of $1.0 on revenue of $83.11 million. In the same quarter last year, National Health Investors reported earnings per share of $1.36 on revenue of $78.10 million. The analyst consensus estimate would represent a 26.47% decline in the company's EPS figure. Here's how the company's reported EPS has stacked up against analyst estimates in the past:Quarter Q1 2020 Q4 2020 Q3 2019 Q2 2019 EPS Estimate 0.95 0.94 0.95 0.95 EPS Actual 1.36 1.41 1.42 1.36 Revenue Estimate 83.09 M 80.76 M 80.29 M 73.67 M Revenue Actual 83.08 M 82.19 M 81.68 M 78.10 M Stock Performance Over the past 52-week period, shares of National Health Investors have declined 21.73%. Given that these returns are generally negative, long-term shareholders are probably a little upset going into this earnings release.View more earnings on NHIDon't be surprised to see the stock move on comments made during its conference call. National Health Investors is scheduled to hold the call at 12:00:00 ET and can be accessed here: https://www.webcaster4.com/Webcast/Page/633/35812See more from Benzinga * Integra Lifesciences Earnings Preview * Earnings Outlook For Kforce * Earnings Preview for ANGI Homeservices(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.